99% Purity CAS 36703-88-5 Inosine Pranobex Powder Pharmaceutical Research Inosine Pranobex Material Inosine Pranobex

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Inosine Pranobex
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Inosine Pranobex
• Name: Inosine Pranobex Powder
• Appearance: White Crystalline Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 36703-88-5
• Mf: C52h78n10o17
• MW: 1115.23
• Einecs No.: 253-162-1
• Boiling Point: 732.8 C at 760 Mmhg
• Melting Point: 140-145 C
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 500kg/Month

Product Description

99% Purity CAS 36703-88-5 Inosine Pranobex Powder Pharmaceutical Research Inosine Pranobex Material Inosine Pranobex

 

Product Description

Product Details

Product Name	Inosine Pranobex
CAS No.	36703-88-5
Purity	99%
MW	1115.23
Appearance and shape	White crystalline powder

Inosine Pranobex is an organic substance with a chemical formula of C52H78N10O17, slightly yellow or colorless powder, slightly bitter, easy to absorb moisture, soluble in water, is inosine and is combined with dimethylaminoisopropanol and p-acetaminobenzoate Complex.
Inosine Pranobex is an immunomodulatory drug. In vitro experiments have shown that it can enhance the immune response of PHA or antigen, promote the differentiation and proliferation of T lymphocytes, and can stimulate the differentiation of B lymphocytes by activating TH cells or macrophages And produce antibodies.

Application & Function

1.Used in the treatment of leucopenia and thrombocytopenia.
2.Used for eye diseases (central retinal inflammation, optic atrophy) auxiliary drug use.
3.In the treatment of acute hepatitis and chronic hepatitis and liver cirrhosis, hepatic encephalopathy.
4.Used to prevent and mitigate the schistosomiasis prevention drugs caused bythe heart and the liver toxicity.
5.Used for coronary atherosclerotic heart disease (coronary heart disease), myocardial infarction, rheumatic heart disease, cor pulmonale auxiliary drug use.

Specification